Article info
PDFInflammatory bowel disease
Original article
Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II)
- Correspondence to Dr Silvio Danese, Department of Gastroenterology, Humanitas Clinical and Research Center and Humanitas University, Via Manzoni 56, 20089 Rozzano, Milan, Italy; sdanese{at}hotmail.com
Citation
Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II)
Publication history
- Received May 25, 2017
- Revised November 20, 2017
- Accepted November 22, 2017
- First published December 15, 2017.
Online issue publication
June 15, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/